Alan Colowick

Insider Reports History

Entity
Individual
Location
C/O Threshold Pharmaceuticals, Inc., 1300 Seaport Boulevard, 5 Th Floor, Redwood City, CA
Signature
/s/ Sara Klein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Colowick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALUMIS INC. Director Common Stock 18.4K $138K $7.49 Apr 2, 2025 By Revocable Living Trust
Harpoon Therapeutics, Inc. Director Common Stock 16.5K $133K $8.10 Apr 1, 2023 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 28.6K $40K $1.40 Jun 22, 2022 Direct
Personalis, Inc. Director Common Stock 13.5K $19.9K $1.47 May 17, 2022 Direct
Personalis, Inc. Director Stock Option (right to buy) 40K May 17, 2023 Direct

Insider Reports Filed by Alan Colowick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALMS ALUMIS INC. Apr 1, 2025 2 $130K 4 Apr 3, 2025 Director
MAZE Maze Therapeutics, Inc. Jan 30, 2025 0 $0 3 Jan 30, 2025 Director
ALMS ALUMIS INC. Jun 27, 2024 0 $0 3 Jun 27, 2024 Director
PSNL Personalis, Inc. May 17, 2023 1 $0 4 May 19, 2023 Director
SLRN ACELYRIN, Inc. May 4, 2023 0 $0 3 May 4, 2023 Director
HARP Harpoon Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 2 $40K 4 Jun 24, 2022 Director
PSNL Personalis, Inc. May 17, 2022 2 $0 4 May 19, 2022 Director
PSNL Personalis, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 0 $0 4/A May 14, 2021 Director